Milestone: Creating Innovative Solutions Milestone Home
 
image thru microscope
Symposia Contact Home

CPSA Digest 2004

Integrated Approaches in Drug Discovery & Development: Turning Measurements to Medicine

CPSA Digest 2004

Day 1: Proceedings | Plenary
Day 2: Proceedings
Day 3: Proceedings

CPSA 2004 Sponsors

Past CPSA Digests
CPSA Digest 2000
CPSA Digest 2001
CPSA Digest 2002
CPSA Digest 2003
<>


Day 2 - Wednesday, October 20, 2004

Vendor Session - ACQUITY UPLC™-Quattro Premier ™

Kate Yu, Waters Corporation


  • ACQUITY UPLC™-Quattro Premier ™
    • ACQUITY UPLC™ Column: 1.7 mm, 2.1x50 mm
      • Flow rate:
      • 0.6 ml/minute, no splitting for regular exp.
      • 1 ml/minute with splitting, 400 ml/minute into MS for ESCi
    • Quattro Premier:
      • Minimum dwell time: 5 ms
      • Minimum inter-channel/inter-scan delay: 5 ms
      • Minimum inter-mode delay: 20 ms
      • Multi-mode ionization: Standard
    • Tandem Quadrupole Quantification
      • Improved Speed - Alprazolam in precipitated rat plasma, 10 ng/mL, 5 ml Injection
      • Higher Sensitivity - ACQUITY UPLC™Column 2.1 x 50 mm, 1.7 mm, 0.6 ml/min., no flow splitting; Quattro Premier MS, MRM, Simultaneous polarity switching
      • Linearity - 3 Injections per concentration in precipitated rat plasma (Prednisolone, 361.1>343.5, ESI+ and Ibuprofen, 205.2>161.3, ESI-)
      • System Robustness - 10 ng/mL Standard Spiked in Precipitated Rat Plasma (Alprazolam, Internal Calibration, 5 ms Dwell Time, 5 ms Delay)
      • Negligible Carryover
      • Multi-mode Ionization: ESCi - Simultaneous Electrospray/APCI


Return to Proceedings »



overview | training | workshops | consulting | symposia | contact | home